Psychiatric comorbidities among adult patients with disorders of gut–brain interaction: Prevalence and relationships to treatment outcomes

Abstract

Anxiety disorders are common among patients with DGBI and significantly reduce the likelihood of GI pharmacologic treatment response to any medication prescribed, including neuromodulators.